People should know what they want to achieve
Suneela Thatte, VP and Head – R&D, India, Merck KGaA, in an interaction with Ashwini Prakash, Managing Partner India, Asia…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Hazards of self-medication and urgent need for regulation
Advocate Satya Muley, practising at Bombay High Court, sheds light on the problems caused due to self-medication and the rise in…
Panel Discussion: Biologics and Biosimilars: Challenges and opportunities in FDD
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Panel Discussion: Oral solid dosage forms: Trends and opportunities
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Arjun Singh Dasoondi, AVP, Amway
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Sanjay Negi, GM, Ideal Cures
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Special Address: Dr Ajaz Hussain, Independent Advisor – Life Sciences
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in…
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
Allergan AbbVie in India to continue high focus on eyecare, neurosciences and aesthetics
Suresh Pattathil, MD & GM, Allergan AbbVie updates Viveka Roychowdhury on the operational and cultural integration of Allergan…
South Africa begins trial of new oral drug against COVID-19
South Africa has been struggling with its plans to achieve herd immunity through vaccinations, with widespread vaccine hesitancy,…